Latest Institutional Purchases of Xtl Biopharmaceuticals LTD (XTLB)
This list provides information on the latest institutional transactions involving Xtl Biopharmaceuticals LTD (XTLB) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
4.44K+ 68.03% |
$5.85K - $10.6K
|
11K
$17.6K
|
|
| Q3 2024 | |||||||
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
| Q2 2024 | |||||||
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
1.8K+ 13.23% |
$3.68K - $6.01K
|
15.4K
$24.9K
|
|
| Q1 2024 | |||||||
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
BUY
|
- |
6.9K+ 12777.78% |
$5.52K - $21.2K
|
6.95K
$11.2K
|
|
| Q4 2023 | |||||||
|
Jan 24, 2024
Q4 2023
|
Central Trust CO
Jefferson City, MO |
BUY
|
- |
200New |
$152 - $226
|
200
$322
|
|